A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants
Clinical trial NCT05057949 · COMPLETED
Trial details
- NCT number
- NCT05057949
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2022-02-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.